Furthermore, versican, a large extra-cellular matrix proteoglycan, enhances cancer metastasis through TLR2/6-Tpl2 mediated activation of myeloid cells in the metastatic niche [6,26,91,92,93]. This evidence concerns the gene TLR2 and cancer.